Protective immunity against SARS-CoV-2 could last eight months or more
New data suggest that nearly all COVID-19 survivors have the immune cells necessary to fight re-infection. The findings, based on […]
» Read moreA coronavirus variant identified in South Africa may not be as vulnerable to COVID-19 vaccines as other strains, some scientists […] It’s been shown that when two people wearing masks interact, the chance of COVID-19 transmission is drastically reduced. This is […] The global community is missing the chance to end the “modern tragedy” of tuberculosis, the biggest infectious killer, experts said […] Yale researchers have discovered a protein that helps protect hosts from infection with the tick-borne spirochete that causes Lyme Disease, […] TUESDAY, Nov. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. and […] A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at […] TUESDAY, Oct. 13, 2020 — A study to assess whether certain approved or experimental drugs are effective against COVID-19 and […] A new paper in Nature Communications outlines how an international research team has identified potential ways forward to rapidly design […] Research led by Jeff Gidday, Ph.D., Professor of Ophthalmology, Biochemistry, Neuroscience, and Physiology at LSU Health New Orleans School of […]
COVID-19 vaccines may not work as well against South African variant, experts worry
Researchers rank various mask protection, modifications against COVID-19
Coronavirus crippling fight against other pandemic: TB
Scientists identify protein that protects against Lyme
New Antibody Treatment Approved for Emergency Use Against Early COVID
Trial will test existing drugs against rare blood cancer
NIH Launches Trial of Antibody Drugs Against COVID-19
Research identifies new information to accelerate structure-based drug design against COVID-19
Study first to show non-harmful stress protects against disease in offspring
